GNeosomes, lysosomotropic lipid vesicles decorated with guanidinoneomycin, can encapsulate and facilitate the cellular internalization and lysosomal delivery of cargo ranging from small molecules to high molecular weight proteins, in a process that is exclusively dependent on cell surface glycosaminoglycans. Their cellular uptake mechanism and co-localization with lysosomes, as well as the delivery, release, and activity of internalized cargo, are quantified. GNeosomes are proposed as a universal platform for lysosomal delivery with potential as a basic research tool and a therapeutic vehicle
There are at least 50 lysosomal storage diseases that are caused by accumulation of a substrate due ...
In the present study the use of extracellular vesicles (EVs) as vehicles for therapeutic enzymes in ...
Glycogenosis type II, or Pompe Disease, is a lysosomal storage disease caused by the deficiency of a...
GNeosomes, lysosomotropic lipid vesicles decorated with guanidinoneomycin, can encapsulate and facil...
Two methods for assembling guanidinoneomycin-decorated liposomes are presented and their ability to ...
Advancement and investigation of cellular delivery vehicles using guanidinoglycosides for the transp...
High molecular weight and highly-charged biomolecules are emerging as drugs with high selectivity an...
Targeted delivery of lysosomal enzymes to the endocytic compartment of human cells represents a tran...
Drug discovery and cellular biology research have often been hindered by passage of large, charged m...
WOS: 000367015600006PubMed ID: 26517135A new platform for drug, gene and peptide-protein delivery is...
Item does not contain fulltextThe implementation of efficient strategies for cellular delivery is th...
Glucan particles (GPs) are monodisperse microspheres derived from baker's yeast and represent an int...
In designing a new drug, considering the preferred route of administration, various requirements mus...
In designing a new drug, considering the preferred route of administration, various requirements mus...
Nanocarriers can be useful tools for delivering drugs to the central nervous system (CNS). Their dis...
There are at least 50 lysosomal storage diseases that are caused by accumulation of a substrate due ...
In the present study the use of extracellular vesicles (EVs) as vehicles for therapeutic enzymes in ...
Glycogenosis type II, or Pompe Disease, is a lysosomal storage disease caused by the deficiency of a...
GNeosomes, lysosomotropic lipid vesicles decorated with guanidinoneomycin, can encapsulate and facil...
Two methods for assembling guanidinoneomycin-decorated liposomes are presented and their ability to ...
Advancement and investigation of cellular delivery vehicles using guanidinoglycosides for the transp...
High molecular weight and highly-charged biomolecules are emerging as drugs with high selectivity an...
Targeted delivery of lysosomal enzymes to the endocytic compartment of human cells represents a tran...
Drug discovery and cellular biology research have often been hindered by passage of large, charged m...
WOS: 000367015600006PubMed ID: 26517135A new platform for drug, gene and peptide-protein delivery is...
Item does not contain fulltextThe implementation of efficient strategies for cellular delivery is th...
Glucan particles (GPs) are monodisperse microspheres derived from baker's yeast and represent an int...
In designing a new drug, considering the preferred route of administration, various requirements mus...
In designing a new drug, considering the preferred route of administration, various requirements mus...
Nanocarriers can be useful tools for delivering drugs to the central nervous system (CNS). Their dis...
There are at least 50 lysosomal storage diseases that are caused by accumulation of a substrate due ...
In the present study the use of extracellular vesicles (EVs) as vehicles for therapeutic enzymes in ...
Glycogenosis type II, or Pompe Disease, is a lysosomal storage disease caused by the deficiency of a...